Study explores how environmental exposures before conception may impact fetal development
GRAND RAPIDS, Mich. (March 16, 2021) — Older age at the time of conception and alcohol consumption during pregnancy have long been known to impact fetal development.
Now, a new report published in Proceedings of the National Academy of Sciences suggests older age and alcohol consumption in the year leading up to conception also may have an impact by epigenetically altering a specific gene during development of human eggs, or oocytes.
Although the study did not determine the ultimate physical effects of this change, it provides important insights into the intricate relationship between environmental exposures, genetic regulation and human development.
“While the outcome of the change isn’t clear, our findings give us a valuable look into how environmental factors affect gene regulation through epigenetics and imprinting,” said Peter A. Jones, Ph.D., D.Sc. (hon), Van Andel Institute chief scientific officer and the study’s senior author. “A better understanding of these complex processes further our understanding of health and disease and — one day — may be the foundation for new disease prevention measures.”
Today’s study centers on a gene called nc886, which is one of about 100 “imprinted” genes that pass from the mother to the fetus. Imprinted genes retain important chemical tags applied by either the mother or the father before conception. The result is an “epigenetic memory” through which non-genetic information, such as maternal age, may flow directly from parent to offspring. To date, nc886 is the only known imprinted gene that exhibits variation in the likelihood of imprinting based on maternal factors.
Using data from 1,100 mother-child pairs from South Africa, Jones and colleagues found the imprinting of nc886 was increased in older mothers but decreased in mothers who drank alcohol the year before conception. The team also investigated cigarette smoking but found no impact on imprinting of nc886.
A 2018 study published by Jones and his collaborators demonstrated that failure to imprint nc886 was associated with higher body mass in children at five years of age. Research by other groups also have linked failure to imprint nc886 with increased survival in people with acute myeloid leukemia, an aggressive type of blood cancer. Most recently, a group in Taiwan found that lack of imprinting on nc886 may reduce response to an anti-diabetic drug.
Authors include Brittany L. Carpenter, Ph.D., Tanaka K. Remba, Stacey L. Thomas, Ph.D., Zachary Madaj, M.S., and Rochelle L. Tiedemann, Ph.D., of VAI; and Lucy T. Brink, M.Sc., and Hein J. Odendaal, M.B.Ch.B., F.C.O.G.(S.A.), M.Med., M.D., F.R.C.O.G., of Stellenbosch University. The VAI Bioinformatics and Biostatistics Core contributed to this work. Blood spot and cord blood samples were provided by the Prenatal Alcohol and SIDS and Stillbirth Network.
Research reported in this publication was supported by Van Andel Institute and the National Institute of General Medical Sciences of the National Institutes of Health under Award Number F32GM129987 (Carpenter). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The Safe Passage Study, which provided access to samples and drinking and smoking data, was funded by the National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Institute on Deafness and Other Communication Disorders under award numbers U01 HD055154, U01 HD045935, U01 HD055155, U01 HD045991 and U01 AA016501 (Odendaal).
ABOUT VAN ANDEL INSTITUTE
Van Andel Institute (VAI) is committed to improving the health and enhancing the lives of current and future generations through cutting edge biomedical research and innovative educational offerings. Established in Grand Rapids, Michigan, in 1996 by the Van Andel family, VAI is now home to more than 400 scientists, educators and support staff, who work with a growing number of national and international collaborators to foster discovery. The Institute’s scientists study the origins of cancer, Parkinson’s and other diseases and translate their findings into breakthrough prevention and treatment strategies. Our educators develop inquiry-based approaches for K-12 education to help students and teachers prepare the next generation of problem-solvers, while our Graduate School offers a rigorous, research-intensive Ph.D. program in molecular and cellular biology. Learn more at vai.org.
Beth Hinshaw Hall
Related Journal Article